Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 1/2 1

Status

Completed 10Not yet recruiting 3Terminated 2Active not recruiting 2Unknown 1Recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3CNS 3Breast 3Gynecologic 2

Conditions

Urinary Bladder Neoplasms 1Prostatic Neoplasms 1Erectile Dysfunction 1Carcinoma, Renal Cell 1

Interventions

Gemcitabine 13Radiotherapy 12Androgen Antagonists 12Specimen Handling 11Magnetic Resonance Spectroscopy 10pembrolizumab 9Nivolumab 8toripalimab 7darolutamide 7Drug Therapy 7Radiosurgery 6Docetaxel 6Cystectomy 6enzalutamide 5apalutamide 5Mitomycin 5Cisplatin 5Axitinib 5Abiraterone Acetate 5disitamab vedotin 4cabozantinib 4abiraterone 4Pluvicto 4Cyclophosphamide 4tislelizumab 3lenvatinib 3fludarabine 3cemiplimab 3Sunitinib 3Standard of Care 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Saline Solution × Genitourinary × Clear all
NCT07048314 2026-03-19

Stem Cells for Erectile Dysfunction Post RALP

The Methodist Hospital Research Institute

Phase 1/2 Not yet recruiting
40 enrolled
Genitourinary

Erectile Dysfunction, Prostatic Neoplasms

NCT07125924 2025-08-15

Intravesical Hyaluronic Acid (HA) for Preventing Radiation Cystitis on Bladder Cancer

National Cancer Center, Korea

Phase NA Not yet recruiting
54 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT06146777 2023-11-29

Multi-classifier System for Stratifying Stage III Papillary Renal Cell Carcinoma of Receiving Adjuvant Therapy

First Affiliated Hospital, Sun Yat-Sen University

Phase 3 Not yet recruiting
468 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡